Challenge
Organon, a spin-out pharma company focused on women’s health, needed to develop an ESG strategy from scratch, and quickly.
Solution
Organon used Datamaran to benchmark against its peers, conduct a materiality analysis and combine this data with insights from stakeholders faster and more effectively.
Result
By using Datamaran, Organon was able to quickly carry out a materiality analysis and build its ESG strategy. It continues to monitor ESG data to inform executive decision-making.